ArticleBiomimetics (Basel, Switzerland)2025
Research on the Optimization of Uncertain Multi-Stage Production Integrated Decisions Based on an Improved Grey Wolf Optimizer.
Article in Biomimetics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Defect-rate uncertainty creates cascading operational challenges in multi-stage production, often driving inefficiency and misallocation of labor, materials, and capacity. To confront this, we develop a multi-stage Production Integrated Decision (MsPID) framework that unifies quality inspection and shop-floor decision-making within a single computational model. The framework couples a two-stage sampling inspection policy-used to statistically learn and control defect-rate uncertainty via estimation and rejection rules-with a multi-process, multi-part production decision model. Optimization is carried out with an Improved Grey Wolf Optimizer (IGWO) enhanced with Latin hypercube sampling (LHS) for uniformly diverse initialization; an evolutionary factor mechanism that blends simulated binary crossover (SBX) among three leadership-guided parents (Alpha, Beta, Delta) to strengthen global exploration in early iterations and focus exploitation later; and a greedy, mutation-assisted opposition learning step applied to the lowest-performing quartile of the population to effect leader-informed local refinement and accept only fitness-improving moves. Experiments show the method identifies minimum-cost policies across six single-stage benchmark cases and yields a total profit of 43,800 units in a representative multi-stage scenario, demonstrating strong performance in uncertain environments. Sensitivity analysis further clarifies how recommended decisions adapt to shifts in estimated defect rates, finished product prices, and swap/changeover losses. These results highlight how bio-inspired intelligence can enable adaptive, efficient, and resilient integrated production management at scale.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.